Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1201-1204

  Zelada Hedman, M ^a,b   Borresen Dale A L ^b   Claro, A ^a   Chen, J ^a   Skoog, L ^a   Lindblom, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Constant denaturant gel electrophoresis; Familial breast cancer; Mutation analysis; p53; TP53

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER GENETICS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC SCREENING; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030942880     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.205     Document Type: Article

References (21)

1. Andersen TI and Boørresen A-L (1995) Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas. Advantages of using constant denaturant gel electrophoresis in mutation detection. Diag Mol Pathol 4: 203-211
2. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB. Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibánez-Koref MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304
3. Børresen A-L, Hovig E, Smith-Soørensen B, Malkin D, Lystad S, Andersen TI, Nesland JM. Isselbacker KJ and Friend SH (1991) Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 88: 8405-8409
4. Børresen A-L, Ikdahl Andersen T, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E. Malkin D and Friend SH (1992) Screening for germ line tp53 mutations in breast cancer patients. Cancer Res 52: 3234-3236
5. Glebov OK, McKenzie KE, White CA and Sukumar S (1994) Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 54: 3703-3709
6. Hollslein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Soørensen B, Montesano R and Harris CC (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555
7. Ishimaru G, Ookawa K, Yamaguchi N, Sakamoto M, Hirohashi S. Muto T and Yokota J (1994) Allelic losses associated with the metastatic potential of colorectal carcinoma, Int J Oncol 5: 267-273
8. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE and Look AT (1994) Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 9: 97-102
9. Lidereau R and Soussi T (1992) Absence of p53 germ-line mutations in bilateral breast cancer patients. Hum Genet 89: 250-252
10. Lindblom A, Rotstein S, Larsson C. Nordenskjöld M and Iselius L (1992a) Hereditary breast cancer in Sweden: a predominancy of maternally inherited cases. Breast Cancer Res Treat 24: 159-165
11. Lindblom A, Skoog L, Andersen TI, Rotstein S, Nordenskjöld M and Larsson C (1992b) Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas. Hum Genet 91: 6-12
12. Malkin D (1994) Germline p53 mutations and hereditable cancer. Annu Rev Genet 28: 443-465
13. Miki Y, Shattuck-Eidens D. Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennelt IM, Ding W, Bell R, Rosenthal J, Hussey C. Tran T. McLure M, Frye C, Hattier T, Phelps R, Haugen-Strand A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R. Dayanath P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science 266: 66-71
14. Murray V (1989) Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res 17: 8889-8889
15. Prosser J, Elder PA, Condie A, MacFadyen I, Steel CM and Evans HJ (1991) Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer 63: 181-184
16. Prosser J, Porter D, Coles C, Condie A, Thompson AM. Chetty U, Steel CM and Evans HJ (1992) Constitutional p53 mutation in a non-li-fraumeni cancer family. Br J Cancer 65: 527-528
17. Sidransky D, Tokino T, Helzlsouer K. Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B and Davidson N (1992) Inherited p53 gene mutations in breast cancer. Cancer Res 52: 2984-2986
18. Smith-Sørensen B, Gebhardt MC, Kloen P, McIntyre J, Aguilar F, Cerulti P and Børrensen A-L (1993) Screening for lp53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE). Hum Mut 2: 274-285
19. Syvänen A-C, Aalto-Setälä K, Kontula K and Söderlund H (1989) Direct sequencing of affinity-captured amplified human DNA application to the detection of apolipoprotein E polymorphism. FEBS lett 258: 71-74
20. Wang Q, Lasset C, Sobol H and Ozlurk M (1996) Evidence of a hereditary p53 syndrome in cancer-prone families. Int J Cancer 65: 554-557
21. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Magion J, Collins N, Gregory S, Gumbs C, Hicklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futrcal PA, Ashworth A and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792